Toinv - Thanks for your thoughts. Every one of them has crossed my mind, and a whole lot more.

Access to senior people - apparently that changed somewhere around April last year after they presented at a Bio conference in Europe. I didn't hear why but that was apparently the turning point. Something to do with a presentation Dr K made.

FDA approval of BETonMACE could definitely be a game changer for RVX.

There has been some pretty amazing drugs developed in the EU that did not get FDA approval for quite some time. There is currently legislation in process in the US to level that playing field from what I have heard.

PFE paid $14 billion for Medivation. It doesn't really matter though as we would be happy with any number like 14, 24 or 28.

If this story ever plays out like it has the potential to, Don will be a campion, if not, just a chump. His major job is to make sure there is money to keep it all going so the scientists can continue to do there thing. So far we are led to believe the science is looking good in this current trial but I'm no scientist.

Keep your ideas coming Toinv.

tada